GFM
KNSA icon

GF Fund Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

GF Fund Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.2K Sell
973
-42
-4% -$2.18K ﹤0.01% 369
2026
Q1 		$48.9K Buy
1,015
+128
+14% +$5.67K ﹤0.01% 401
2025
Q4 		$36.6K Sell
887
-48
-5% -$1.93K ﹤0.01% 434
2025
Q3 		$36.3K Sell
935
-129
-12% -$4.19K ﹤0.01% 427
2025
Q2 		$29.4K Hold
1,064
– – ﹤0.01% 462
2025
Q1 		$23.6K Buy
1,064
+191
+22% +$3.93K ﹤0.01% 487
2024
Q4 		$17.3K Buy
+873
New +$19.9K ﹤0.01% 485

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

GF Fund Management's KNSA Position: Q2 2026 in Review

GF Fund Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 4.1% in Q2 2026, selling an estimated $2.18K and leaving 973 shares worth $62.2K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

GF Fund Management first reported a position in KNSA in Q4 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • GF Fund Management held 973 shares of Kiniksa Pharmaceuticals worth $62.2K as of Q2 2026.
  • GF Fund Management sold 42 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $2.18K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #369 holding.
  • GF Fund Management first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.